Posts by Sandra Ansanay-Alex
A paraplegic controls his movements with his mind
Neuroscientists and neurosurgeons from EPFL/CHUV/UNIL and CEA/CHUGA/UGA report in the journal Nature that they have re-established communication between the brain and the spinal cord with a wireless digital bridge, allowing a paralyzed person to walk again naturally. “We have developed a wireless digital bridge between the brain and the spinal cord using Brain-Computer…
Read More6 life sciences startups in the Top 10 of the W. A. de Vigier Award
From a record number of over 300 submitted projects, the jury picked their Top 10. On 20 June 2023, up to five of those young leaders will receive a W. A. de Vigier Award, each endowed with CHF 100,000 biped AG from Epalinges (VD) – Independence for the Visually Impaired 270 million visually impaired…
Read MoreFluosphera SA, Kylys Aesthetics SA and Consulto supported by FONGIT
Fongit, the Fondation Genevoise pour l’Innovation Technologique, has awarded two Seed loans of 100,000 CHF to Fluosphera SA and Kylys Aesthetics SA respectively and a grant of 50,000 CHF to Consulto. The FIF (FONGIT Innovation Fund) is the instrument for fostering innovation and scale up of promising companies from the Canton of Geneva at…
Read MoreWestern Switzerland cantons sign an agreement on digital health
Fribourg, Geneva, Jura, Valais and Vaud are aiming to establish a legal basis for the provision and operation of other digital health services. The health ministers of the French-speaking cantons are strengthening their collaboration in the area of digital health. They are establishing a common framework for the joint development of new technology-based tools that…
Read MoreOnward Announces First-in-Human Use of ARC-IM™ Lead to Restore Movement and Function after Spinal Cord Injury
New lead is purpose-designed to optimize the delivery of ONWARD ARC Therapy™ ONWARD Medical, a medical technology company working in partnership with EPFL, CHUV and UNIL, is creating innovative therapies to restore movement, function, and independence in people with spinal cord injury (SCI), announced the successful firstin-human use of its investigational ARC-IM Lead. …
Read MoreSwiss Symposium in Point of Care Diagnostics
The 9th Edition of the Swiss POC Symposium is taking place on 29 and 30 October 2026 in Winterthur Building on the strong foundation of previous editions, this year’s event offers a dynamic two-day format designed to bring together experts from the medical field, the IVD industry, and cutting-edge research. The Swiss POC Symposium…
Read MoreInvestors et Innovators Connect
On 2 May 2023, BioAlps and Intuitive Surgical co-organised an Investors et Innovators Connect event. Our association scouted projects in which Intuitive Ventures might have an interest to invest. For this event, 10 start-ups were selected. 5 of them pitched their projects in front of an audience composed of investors, as well as innovation…
Read MoreCHF 1 Million for a clinical study on Lymphoma
Dr Noémie Lang, oncologist at Geneva University Hospital (HUG), wins the prestigious Swiss Group for Clinical Cancer Research (SAKK) Trial Network Award. Lymphomas are cancers that originate from white blood cells and affect the lymphatic system, which plays a major role in immune defense. According to the World Health Organization (WHO), they account…
Read MoreBIND: Bioinnovation Day Awards
On 11 May 2023, 31 early stage life sciences projects were presented to the public at the AGORA (Fondation ISREC) near the CHUV in Lausanne, during the Bioinnovation Day. Three of them received and award. The BIND is an event was organised the PACTT, the Technology transfer office of University of Lausanne (UNIL) and…
Read MoreNewBiologix is betting on the industrialization of gene therapy
With CHF 45 million raised, the start-up NewBiologix, officially launched on 11 May 2023 at the Biopôle in Epalinges, has very high ambitions. Its two founders, Igor Fisch and Nicolas Mermod, want to reproduce the model that they had successfully implemented in Geneva with their previous company, Selexis. NewBiologix SA emerged from stealth…
Read More